Semaglutide Tablet

Semaglutide Tablet is a diabetes treatment medication. It is marketed under the brand name Ozempic and is administered as a subcutaneous injection rather than a tablet. Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class of drugs. It works by stimulating pancreatic insulin release and decreasing the amount of glucose produced by the liver. It also aids in the slowing of food digestion and absorption in the intestine. It is typically injected once a week, at the same time each week, with or without food, unless otherwise directed by a healthcare provider. The dosage and duration of treatment are determined by the patient's specific needs.